Deliver Your News to the World

Frost & Sullivan Lauds Acclarent’s Pioneering Approach to Relieving Sinusitis


Palo Alto, Calif. — August 24, 2006 — Frost & Sullivan selected Acclarent, Inc. as the recipient of the 2006 Innovation & Advancement Award in the North American medical device industry for developing its trailblazing Sinuplasty approach for treating chronic sinusitis.

Acclarent’s groundbreaking product offers a minimally invasive interventional approach to curing chronic sinusitis. Patients and specialists are beginning to recognize alternative avenues of treatment to enhance or even displace the old industry standards.

Acclarent’s unique catheter approach arrives at a time when the medical industry is shifting toward minimally invasive surgical approaches. In the past, sinus surgery would have required opening up and exposing tissues and the mucosa by means of deep incisions in the face. Those surgical procedures leave scars, require additional hospital stay due to extended recovery times, and dramatically increase the risk of sepsis or infection.

“Due to the easy access provided by the nasal cavity, the Acclarent approach does not require the removal of bone or disruption of ancillary tissue,” says Frost & Sullivan Research Analyst Venkat Rajan. “Moreover, due to the simplicity of the procedure, patients are free to return to regular activities the same day.”

Acclarent’s dedication to providing thorough in-depth clinical information is helping spur the proliferation of its technology. Using its in-depth web portal targeted at both patients and clinicians alike, Acclarent is helping to increase the awareness of its Sinuplasty approach.

“In the future, it is possible that other medical device innovators will recognize the possibility of providing effective medical device solutions to chronic treatment resistant disorders and follow the example set by companies such as Acclarent,” observes Rajan.

Each year Frost & Sullivan presents this Award to a company that has proven to be a leader in the industry and has been successful in moving the state of the industry forward through its pioneering technology, sound business strategy, and research efforts. Its excellence in the field has extended beyond its technical advancements and encompasses a comprehensive view of market participants, resulting in an ongoing improvement in the industry over time.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Acclarent, Inc.

The company is committed to the ear, nose, and throat space and is dedicated to developing new technologies to further meet the needs of ENT patients.

Initially, it is focused on enhancing the goals of sinus surgery with its novel, endoscopic, catheter-based tools - Balloon Sinuplasty™ devices. Through the Balloon Sinuplasty™ technology and Relieva™ product portfolio, it offers ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in early 2005 and the products were commercially launched in the United States later that same year.

Through its core technologies and commitment to innovation, Acclarent™ will continue to advance novel devices in all areas of ENT.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit or


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.